Back to CHRS Stock Lookup

Coherus BioSciences (CHRS) – Corporate News

Aug 9, 2016 01:55 PM Coherus BioSciences (CHRS) Announces Submission of CHS-1701 BLA to U.S. FDA Under 351(k) Pathway
Aug 8, 2016 08:38 AM Coherus BioSciences (CHRS) Announces CHS-1420 Phase 3 Met Primary Endpoint
Jul 11, 2016 08:32 AM Coherus BioSciences (CHRS) CHS-1701 Follow-on Study Met All co-Primary Endpoints
Jun 13, 2016 02:05 PM Coherus BioSciences (CHRS) Announces Favorable PTAB Decision for IPR Petitions (ABBV)
Jun 10, 2016 12:06 PM Coherus BioSciences (CHRS) Announces Results of Study Demonstrating CHS-0214 Equivalence to Enbrel
May 26, 2016 03:30 PM Coherus BioSciences (CHRS) Issued Three U.S. Patents Related to CHS-1420
May 23, 2016 09:20 AM Coherus BioSciences (CHRS) Prices 3.5M Stock Offering at $18/Share
May 23, 2016 06:14 AM Coherus BioSciences (CHRS) Plans 3.5M Common Stock Offering
May 17, 2016 10:36 AM Coherus BioSciences (CHRS) Receives Favorable PTAB Decision in ‘135 IPR (ABBV)
Feb 29, 2016 09:46 AM Coherus BioSciences (CHRS) Enters $100M Conv. Notes Private Placement
Feb 1, 2016 04:13 PM Coherus BioSciences (CHRS) Annoucnes CHS-1701 Immunogenicity Study Met All Endpoints
Jan 11, 2016 06:48 AM Coherus BioSciences (CHRS), Baxalta (BXLT) Announce CHS-0214 Phase 3 Met Primary Endpoint in RA
Dec 21, 2015 09:32 AM Coherus BioSciences (CHRS) Announces Manufacturing Agreement for CHS-1701
Dec 14, 2015 04:45 PM Coherus BioSciences (CHRS) Receives $35M Milestone from Baxalta (BXLT)
Dec 8, 2015 04:01 PM Coherus BioSciences (CHRS) Plans Follow-on Study for CHS-1701 Program
Nov 9, 2015 04:41 PM Coherus Bio (CHRS), Baxalta (BXLT) Announced CHS-0214 Met Primary Efficacy Endpoints in Phase 3 Psoriasis Study
Oct 1, 2015 04:11 PM Coherus BioSciences (CHRS) Study of CHS-1701 Met Primary PD Endpoint
Oct 1, 2015 04:11 PM Coherus BioSciences (CHRS) Announces CHS-1701 Met Primary PD Endpoints in PK/PD Study; Some Data Still Under Review
Sep 3, 2015 04:15 PM Coherus BioSciences (CHRS) Increases Enrollment in CHS-1701 Study, Begins Enrollment for CHS-1420
Apr 1, 2015 05:55 AM Coherus BioSciences (CHRS) Prices Larger 4.14M Common Offering at $29/Share
Mar 28, 2011 04:14 PM Inter Parfums (IPAR) Announces Exclusive Agreement with Charming Shoppes' (CHRS) Lane Bryant Brand
Jul 13, 2009 11:09 AM Charming Shoppes (CHRS) Names Several Exec, Mgmt Appointments; Ceases Exploration of Sale of Figi's Food Unit
Jan 15, 2009 06:04 PM Charming Shoppes (CHRS) Announces Another 225 Job Cuts; Reports Holiday Sales Decline
Nov 17, 2008 09:19 AM Charming Shoppes (CHRS) Completes Sale of Misses Catalog Credit Receivables to Alliance Data Systems
Oct 22, 2008 05:19 PM S&P Announces Changes to US Indices: CLHB for DRS, CFL for CHRS, FULT for FDRY, CRVL for OMN
Sep 23, 2008 01:26 PM Charming Shoppes (CHRS) Announces Equity Grant Under Nasdaq Rules
Aug 25, 2008 04:25 PM Charming Shoppes (CHRS) Enters Agreements to Sell Non-Core Apparel Catalogs; Explores Sale of Other Business
May 8, 2008 04:03 PM Charming Shoppes (CHRS) Reaches Agreement with Crescendo and Myca Partners to Resolve Proxy Contest
May 5, 2008 06:15 PM Charming Shoppes' Settlement Offer to Crescendo and Myca Rejected; Announces Enhancements to Corporate Governance Practices
Apr 29, 2008 03:25 PM Charming Shoppes (CHRS) Issues Statement in Response to RiskMetrics Group
Apr 25, 2008 08:51 AM Charming Shoppes (CHRS) Announces Exploration of Strategic Alternatives
Apr 17, 2008 05:56 PM Charming Shoppes (CHRS) Mails Letter to Shareholders
Aug 15, 2007 01:24 PM Summary of Loeb's Third Point LLC 13F
Aug 25, 2006 06:23 PM Charming Shoppes (CHRS) Replaces GTECH Holdings (GTK) in S&P MidCap 400

Back to CHRS Stock Lookup